prostate

Everlight Radiology and The HLH Imaging Group (HLH), both leading providers in teleradiology and subspecialist reporting services, today announce a strategic partnership to deliver highly specialist cardiac CT/MRI and advanced prostate MRI reporting services to NHS trusts across the UK. This partnership brings together Everlight Radiology’s established operational scale, resilient service delivery model and experience […]

Provider of lung cancer screening in England, The HLH Imaging Group has used its nationally-integrated NHS architecture, AI-supported approach and collaboration with leading figures in prostate imaging to add a prostate MRI reporting arm that now provides services to several NHS and independent institutions. Using the DeepHealth Prostate AI platform, HLH Prostate provides NHS trusts […]

The Northern Centre for Cancer Care (NCCC) in Newcastle has reached a significant milestone, treating more than 1,000 prostate cancer patients using an automated radiotherapy planning system that is helping deliver faster and more consistent care. The Varian Edge system enables the team to create radiotherapy treatment plans more efficiently and with greater precision. Normally, […]

Momentm Health is an exciting new independent healthcare provider of expert diagnostics and therapeutic procedures located in the heart of Cambridgeshire. Founded by a team of experienced clinicians from Cambridge hospitals, Momentm Health brings together world-leading orthopaedic surgeons, rheumatologists, sports medicine specialists and radiologists with a mission to provide swift, high-quality diagnostic care. Founded in […]

At this year’s ESTRO Congress in Vienna, Austria, Micropos Medical hosted a seminar on augmented stereotactic body radiation therapy (SBRT), a concept encompassing technologies for motion tracking and enhanced methods for accuracy in radiotherapy for prostate cancer, with a focus on treatment outcomes and quality of life. The seminar brought together experts in the field […]

Edinburgh Cancer Centre has recently begun treating prostate cancer patients within the framework of the Precision Study. Patients receive only three radiation doses, with the Raypilot System used as a complement to ensure accurate motion control during treatment, thereby minimising potential side effects. The aim is to demonstrate that three sessions work as well as […]

Men with localised prostate cancer are often faced with the choice of treating the disease with surgery or radiation. Both methods are equally effective in curing the cancer, but the extent of potential side effects varies. A long-term study shows that sexual function deteriorates significantly more, and for more patients, following surgery. Urinary incontinence issues […]

Results have been published from a British long-term follow-up study of 874 prostate cancer patients who received either conventional radiation therapy in 20 or 39 sessions or stereotactic body radiotherapy (SBRT) involving higher radiation doses in five sessions. The results showed that treatment outcomes are equally effective for patients treated five times compared to those […]